Recherchemedicale.com
Tumeurs
Tumeurs par type histologique
Tumeurs épithéliales épidermoïdes et glandulaires
Tumeurs kystiques, mucineuses et séreuses
Cystadénocarcinome
Cystadénocarcinome mucineux
Cystadénocarcinome mucineux : Questions médicales fréquentes
Diagnostic
5
Cystadénocarcinome
Biopsie
Imagerie médicale
Échographie
Tomodensitométrie
IRM
Marqueurs tumoraux
CA-125
Cystadénocarcinome
Histopathologie
Cystadénocarcinome
Diagnostic
Échographie
Tumeurs ovariennes
Cystadénocarcinome
Symptômes
5
Symptômes
Douleurs abdominales
Troubles digestifs
Symptômes
Douleurs pelviennes
Irrégularités menstruelles
Ascite
Perte de poids
Cystadénocarcinome
Syndrome de l'intestin irritable
Symptômes
Cystadénocarcinome
Asymptomatique
Cystadénocarcinome
Symptômes
Prévention
5
Prévention
Cystadénocarcinome
Suivi médical
Facteurs de risque
Antécédents familiaux
Mutations génétiques
Mode de vie
Prévention
Cancers
Contraceptifs oraux
Prévention
Cystadénocarcinome
Dépistage
Cystadénocarcinome
Prévention
Traitements
5
Chirurgie
Chimiothérapie
Radiothérapie
Chirurgie
Cystadénocarcinome
Traitement
Chimiothérapie
Cystadénocarcinome
Traitement
Radiothérapie
Cystadénocarcinome
Traitement
Traitements ciblés
Cystadénocarcinome
Recherche
Complications
5
Complications
Récidive tumorale
Métastases
Métastases
Symptômes
Cystadénocarcinome
Chirurgie
Complications
Infections
Chimiothérapie
Radiothérapie
Effets secondaires
Gestion des complications
Suivi médical
Cystadénocarcinome
Facteurs de risque
5
Facteurs de risque
Antécédents familiaux
Mutations BRCA
Âge
Facteurs de risque
Cystadénocarcinome
Antécédents de cancer
Facteurs de risque
Cystadénocarcinome
Tabagisme
Facteurs de risque
Cancers
Déséquilibres hormonaux
Facteurs de risque
Cystadénocarcinome
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Cystadénocarcinome mucineux : Questions médicales les plus fréquentes",
"headline": "Cystadénocarcinome mucineux : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Cystadénocarcinome mucineux : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-31",
"dateModified": "2025-01-25",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Cystadénocarcinome mucineux"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Cystadénocarcinome",
"url": "https://recherchemedicale.com/mesh/D003536",
"about": {
"@type": "MedicalCondition",
"name": "Cystadénocarcinome",
"code": {
"@type": "MedicalCode",
"code": "D003536",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C04.557.470.590.480"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Cystadénocarcinome mucineux",
"alternateName": "Cystadenocarcinoma, Mucinous",
"code": {
"@type": "MedicalCode",
"code": "D018282",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Min Sun",
"url": "https://recherchemedicale.com/author/Min%20Sun",
"affiliation": {
"@type": "Organization",
"name": "Department of Pathology, Xiangya Hospital, Central South University Changsha, Hunan, China."
}
},
{
"@type": "Person",
"name": "Xiaobo Peng",
"url": "https://recherchemedicale.com/author/Xiaobo%20Peng",
"affiliation": {
"@type": "Organization",
"name": "Department of Oncology, Changhai Hospital Affiliated to Naval Military Medical University, Shanghai 200433, P.R. China."
}
},
{
"@type": "Person",
"name": "Chengtao Guo",
"url": "https://recherchemedicale.com/author/Chengtao%20Guo",
"affiliation": {
"@type": "Organization",
"name": "Department of Oncology, Changhai Hospital Affiliated to Naval Military Medical University, Shanghai 200433, P.R. China."
}
},
{
"@type": "Person",
"name": "Yanjun Wu",
"url": "https://recherchemedicale.com/author/Yanjun%20Wu",
"affiliation": {
"@type": "Organization",
"name": "CAS Key Laboratory of Nutrition, Metabolism and Food Safety, Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai 200031, P.R. China."
}
},
{
"@type": "Person",
"name": "Mingzhen Ying",
"url": "https://recherchemedicale.com/author/Mingzhen%20Ying",
"affiliation": {
"@type": "Organization",
"name": "Department of Oncology, Changhai Hospital Affiliated to Naval Military Medical University, Shanghai 200433, P.R. China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Mucinous cystadenocarcinoma of the breast: a new entity with broad differentials-a case report.",
"datePublished": "2022-02-28",
"url": "https://recherchemedicale.com/article/35224708",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s43046-022-00112-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Mucinous cystadenocarcinoma of the ovary in a 14-year-old girl: a case report and literature review.",
"datePublished": "2023-07-21",
"url": "https://recherchemedicale.com/article/37479970",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12905-023-02551-5"
}
},
{
"@type": "ScholarlyArticle",
"name": "Mammary mucinous cystadenocarcinoma with long-term follow-up: molecular information and literature review.",
"datePublished": "2023-02-04",
"url": "https://recherchemedicale.com/article/36737820",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13000-023-01302-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Mature cystic teratoma with co-existent mucinous cystadenocarcinoma: describing a diagnostic challenge-a case report.",
"datePublished": "2024-05-05",
"url": "https://recherchemedicale.com/article/38704586",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13256-024-04544-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "A case of pancreatic mucinous cystadenocarcinoma with malignant ascites without recurrence for more than 8 years after surgery.",
"datePublished": "2022-05-11",
"url": "https://recherchemedicale.com/article/35546381",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12328-022-01639-z"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Recherchemedicale.com",
"item": "https://recherchemedicale.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Tumeurs",
"item": "https://recherchemedicale.com/mesh/D009369"
},
{
"@type": "ListItem",
"position": 3,
"name": "Tumeurs par type histologique",
"item": "https://recherchemedicale.com/mesh/D009370"
},
{
"@type": "ListItem",
"position": 4,
"name": "Tumeurs épithéliales épidermoïdes et glandulaires",
"item": "https://recherchemedicale.com/mesh/D009375"
},
{
"@type": "ListItem",
"position": 5,
"name": "Tumeurs kystiques, mucineuses et séreuses",
"item": "https://recherchemedicale.com/mesh/D018297"
},
{
"@type": "ListItem",
"position": 6,
"name": "Cystadénocarcinome",
"item": "https://recherchemedicale.com/mesh/D003536"
},
{
"@type": "ListItem",
"position": 7,
"name": "Cystadénocarcinome mucineux",
"item": "https://recherchemedicale.com/mesh/D018282"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Cystadénocarcinome mucineux - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Cystadénocarcinome mucineux",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-02-02",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Cystadénocarcinome mucineux",
"description": "Comment diagnostiquer un cystadénocarcinome mucineux ?\nQuels tests sont utilisés pour le diagnostic ?\nQuels marqueurs tumoraux sont associés ?\nQuelle est l'importance de l'histopathologie ?\nPeut-on détecter cette tumeur par échographie ?",
"url": "https://recherchemedicale.com/mesh/D018282#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Cystadénocarcinome mucineux",
"description": "Quels sont les symptômes courants ?\nY a-t-il des symptômes spécifiques aux femmes ?\nComment se manifeste une tumeur avancée ?\nLes symptômes peuvent-ils être confondus avec d'autres maladies ?\nLes symptômes sont-ils toujours présents ?",
"url": "https://recherchemedicale.com/mesh/D018282#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Cystadénocarcinome mucineux",
"description": "Peut-on prévenir le cystadénocarcinome mucineux ?\nQuels facteurs de risque sont connus ?\nLe mode de vie influence-t-il le risque ?\nLes contraceptifs oraux aident-ils à prévenir ?\nLe dépistage est-il recommandé ?",
"url": "https://recherchemedicale.com/mesh/D018282#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Cystadénocarcinome mucineux",
"description": "Quels traitements sont disponibles ?\nLa chirurgie est-elle toujours nécessaire ?\nQuel rôle joue la chimiothérapie ?\nLa radiothérapie est-elle efficace ?\nY a-t-il des traitements ciblés disponibles ?",
"url": "https://recherchemedicale.com/mesh/D018282#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Cystadénocarcinome mucineux",
"description": "Quelles complications peuvent survenir ?\nComment les métastases se manifestent-elles ?\nY a-t-il des risques liés à la chirurgie ?\nLes traitements peuvent-ils causer des effets secondaires ?\nComment gérer les complications ?",
"url": "https://recherchemedicale.com/mesh/D018282#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Cystadénocarcinome mucineux",
"description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il le risque ?\nLes antécédents de cancer augmentent-ils le risque ?\nLe tabagisme est-il un facteur de risque ?\nLes déséquilibres hormonaux jouent-ils un rôle ?",
"url": "https://recherchemedicale.com/mesh/D018282#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un cystadénocarcinome mucineux ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'imagerie, l'échographie et la biopsie."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent l'échographie, la tomodensitométrie et l'IRM."
}
},
{
"@type": "Question",
"name": "Quels marqueurs tumoraux sont associés ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le CA-125 est souvent élevé dans les cystadénocarcinomes mucineux."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de l'histopathologie ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'histopathologie permet de confirmer la nature maligne de la tumeur."
}
},
{
"@type": "Question",
"name": "Peut-on détecter cette tumeur par échographie ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'échographie peut révéler des masses ovariennes suspectes."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent douleurs abdominales, ballonnements et troubles digestifs."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques aux femmes ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des irrégularités menstruelles et des douleurs pelviennes peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment se manifeste une tumeur avancée ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une tumeur avancée peut provoquer une ascite et une perte de poids."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils être confondus avec d'autres maladies ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent être similaires à ceux du syndrome de l'intestin irritable."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils toujours présents ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, certains patients peuvent être asymptomatiques au début."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir le cystadénocarcinome mucineux ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode de prévention spécifique, mais un suivi régulier est conseillé."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque sont connus ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux et certaines mutations génétiques augmentent le risque."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain peut réduire le risque de plusieurs cancers, y compris ovarien."
}
},
{
"@type": "Question",
"name": "Les contraceptifs oraux aident-ils à prévenir ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent que les contraceptifs oraux peuvent réduire le risque."
}
},
{
"@type": "Question",
"name": "Le dépistage est-il recommandé ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le dépistage régulier est conseillé pour les femmes à risque élevé."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la chirurgie, la chimiothérapie et la radiothérapie."
}
},
{
"@type": "Question",
"name": "La chirurgie est-elle toujours nécessaire ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la chirurgie est souvent le traitement principal pour enlever la tumeur."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la chimiothérapie ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La chimiothérapie est utilisée pour traiter les tumeurs avancées ou récidivantes."
}
},
{
"@type": "Question",
"name": "La radiothérapie est-elle efficace ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La radiothérapie peut être utilisée en complément, mais moins fréquemment."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements ciblés disponibles ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements ciblés sont en cours d'étude, mais pas encore standardisés."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la récidive tumorale et les métastases."
}
},
{
"@type": "Question",
"name": "Comment les métastases se manifestent-elles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les métastases peuvent affecter d'autres organes, provoquant divers symptômes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques liés à la chirurgie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des complications chirurgicales comme des infections peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les traitements peuvent-ils causer des effets secondaires ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la chimiothérapie et la radiothérapie peuvent entraîner des effets secondaires."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion des complications nécessite un suivi médical régulier et des soins appropriés."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux et les mutations BRCA sont des facteurs de risque majeurs."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque augmente avec l'âge, surtout après 50 ans."
}
},
{
"@type": "Question",
"name": "Les antécédents de cancer augmentent-ils le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, avoir des antécédents de cancer augmente le risque de cystadénocarcinome."
}
},
{
"@type": "Question",
"name": "Le tabagisme est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le tabagisme est associé à un risque accru de plusieurs cancers, y compris ovarien."
}
},
{
"@type": "Question",
"name": "Les déséquilibres hormonaux jouent-ils un rôle ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les déséquilibres hormonaux peuvent influencer le développement de tumeurs ovariennes."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 25/01/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
Department of Pathology, Xiangya Hospital, Central South University Changsha, Hunan, China.
Publications dans "Cystadénocarcinome mucineux" :
2 publications dans cette catégorie
Affiliations :
Department of Oncology, Changhai Hospital Affiliated to Naval Military Medical University, Shanghai 200433, P.R. China.
Publications dans "Cystadénocarcinome mucineux" :
2 publications dans cette catégorie
Affiliations :
Department of Oncology, Changhai Hospital Affiliated to Naval Military Medical University, Shanghai 200433, P.R. China.
Publications dans "Cystadénocarcinome mucineux" :
2 publications dans cette catégorie
Affiliations :
CAS Key Laboratory of Nutrition, Metabolism and Food Safety, Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai 200031, P.R. China.
Publications dans "Cystadénocarcinome mucineux" :
2 publications dans cette catégorie
Affiliations :
Department of Oncology, Changhai Hospital Affiliated to Naval Military Medical University, Shanghai 200433, P.R. China.
Publications dans "Cystadénocarcinome mucineux" :
2 publications dans cette catégorie
Affiliations :
CAS Key Laboratory of Nutrition, Metabolism and Food Safety, Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai 200031, P.R. China.
Publications dans "Cystadénocarcinome mucineux" :
2 publications dans cette catégorie
Affiliations :
CAS Key Laboratory of Nutrition, Metabolism and Food Safety, Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai 200031, P.R. China.
Publications dans "Cystadénocarcinome mucineux" :
2 publications dans cette catégorie
Affiliations :
CAS Key Laboratory of Nutrition, Metabolism and Food Safety, Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai 200031, P.R. China.
Publications dans "Cystadénocarcinome mucineux" :
2 publications dans cette catégorie
Affiliations :
Department of Oncology, Changhai Hospital Affiliated to Naval Military Medical University, Shanghai 200433, P.R. China.
Publications dans "Cystadénocarcinome mucineux" :
2 publications dans cette catégorie
Affiliations :
Glycan & Life Systems Integration Center (GaLSIC), Soka University, Hachioji, Japan.
Department of Biosciences, Graduate School of Science and Engineering, Soka University, Hachioji, Japan.
Publications dans "Cystadénocarcinome mucineux" :
1 publication dans cette catégorie
Affiliations :
Urology, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia.
Publications dans "Cystadénocarcinome mucineux" :
1 publication dans cette catégorie
Affiliations :
Urology, Toowoomba Hospital, Queensland, Australia.
Publications dans "Cystadénocarcinome mucineux" :
1 publication dans cette catégorie
Affiliations :
Urology, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia.
Publications dans "Cystadénocarcinome mucineux" :
1 publication dans cette catégorie
Affiliations :
Urology, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia.
Publications dans "Cystadénocarcinome mucineux" :
1 publication dans cette catégorie
Affiliations :
Department of Experimental, Diagnostic, and Specialty Medicine-DIMES, Sant'Orsola-Malpighi Hospital, University of Bologna, Bologna 40138, Italy.
Publications dans "Cystadénocarcinome mucineux" :
1 publication dans cette catégorie
Affiliations :
Department of Experimental, Diagnostic, and Specialty Medicine-DIMES, Sant'Orsola-Malpighi Hospital, University of Bologna, Bologna 40138, Italy. riccardo.carloni2@studio.unibo.it.
Publications dans "Cystadénocarcinome mucineux" :
1 publication dans cette catégorie
Affiliations :
Division of Oncology, Azienda Ospedaliero-Universitaria di Bologna, Bologna 40138, Italy.
Publications dans "Cystadénocarcinome mucineux" :
1 publication dans cette catégorie
Affiliations :
Radiology Unit, Department of Diagnostic Medicine and Prevention, Sant'Orsola-Malpighi Hospital, University of Bologna, Bologna 40138, Italy.
Publications dans "Cystadénocarcinome mucineux" :
1 publication dans cette catégorie
Affiliations :
Department of Experimental, Diagnostic, and Specialty Medicine-DIMES, Sant'Orsola-Malpighi Hospital, University of Bologna, Bologna 40138, Italy.
Publications dans "Cystadénocarcinome mucineux" :
1 publication dans cette catégorie
Affiliations :
Medical Oncology, Ospedale Degli Infermi, Faenza 48018, Italy.
Publications dans "Cystadénocarcinome mucineux" :
Mucinous cystadenocarcinoma is a rare and recently described primary breast cancer with strikingly similar histomorphology to ovarian, pancreatic, and gastrointestinal counterparts. The diagnosis cann...
We are reporting the case of a 65-year-old woman with primary mucinous cystadenocarcinoma of the breast while exploring clinicopathological features and approach to diagnosis. Though the immunohistoch...
A combined clinic-radio-immunohistochemical approach is essential to make a diagnosis of primary mucinous cystadenocarcinoma....
Ovarian epithelial tumors are common in adults, and their peak incidence of onset is over 40 years of age. In children, most ovarian tumors are germ cell-derived, whereas epithelial tumors are rare an...
This report describes a case of a 14-year-old Chinese girl with ovarian mucinous cystadenocarcinoma. She was admitted with a small amount of bloody vaginal discharge during the past month. Magnetic re...
We report the first pediatric case of ovarian mucinous cystadenocarcinoma in China. Given the scarcity of reports addressing the clinical management of this condition, the present study provides a use...
Mucinous cystadenocarcinoma (MCA) is a very rare form of breast cancer that was first described in 1998. Only 33 cases of primary MCA, including our present case, have been reported thus far. As a con...
A 59-year-old woman presented with a breast lump in which mammography showed a well-defined nodule. Core needle biopsy (CNB) revealed several lesions lined by tall columnar cells with stratification a...
Our study presents the gene profile of an MCA case with no recurrence or metastatic tendency after 108 months of follow-up, and a review of the literature helps us better understand the clinical, path...
Mature cystic teratoma co-existing with a mucinous cystadenocarcinoma is a rare tumor that few cases have been reported until now. In these cases, either a benign teratoma is malignantly transformed i...
In this case, a mature cystic teratoma is co-existed with a mucinous cystadenocarcinoma in the same ovary in a 33-year-old Iranian female. Computed Tomography (CT) Scan with additional contrast of the...
This case shows the significance of large sampling, precise recording of the gross aspects, histopathological examination, immunohistochemical analysis, and the help of radiological and clinical resul...
Mucinous cystadenocarcinoma (MCAC) with malignant ascites is rare. We report a case of a 28-year-old woman who presented with epigastric pain. The ascites in the Douglas fossa was identified at a near...
Mucinous neoplasms are commonly seen in the ovaries and pancreas. Their occurrence in the retroperitoneum is uncommon. We present a case of a retroperitoneal mucinous cystadenocarcinoma in a 54-year-o...
Mucinous cystadenocarcinoma of the breast is a rare primary breast carcinoma having distinct clinical behavior and a favorable prognosis. It has a characteristic morphology that must be differentiated...
Giant ovarian tumors are rare in the present day due to the early diagnosis and treatment. However, owing to the large size, it can often compress the inferior vena cava and sudden decompression of it...
This case report delves into the diagnostic intricacies and clinical management of adult granulosa cell tumour (AGCT) in a woman in her 50s, presenting with pain abdomen. Initial imaging investigation...
Mucinous cystic neoplasms (MCN) are mucin-producing epithelial cell tumors of pancreas. They consist of an ovarian-type stroma expressing estrogen and progesterone receptors. Pregnancy-associated MCNs...
and Data Sources: Systematic review of published literature using PubMed and Google Scholar databases. Original articles including case reports and series published between 1970&2021 were included whe...
Median age at presentation was 32 years. Only three (9%) patients were asymptomatic. Mean size of MCN was 135 mm. Ten patients (27%) reported an increase in size during pregnancy. Most tumors involved...
Pregnancy may cause a rapid increase in size of MCN. Decision-making is more complex and needs a fine balance between optimal oncological and obstetric outcomes....